Just 90 Minutes Of Strength Training A Week Linked To Longer Life
Medically reviewed by Drugs.com
via HealthDayWEDNESDAY, June 3, 2026 — A few sessions in the weight room each week could do more than build muscle — they may help you live longer.
While the evidence linking aerobic exercise to longevity is extensive, little is known about the effects of strength training.
In a study recently published in the British Journal of Sports Medicine, researchers followed more than 147,000 adults for up to 30 years, tracking how much time they spent doing strength training and aerobic exercise.
Strength training ranged from lifting weights to exercises like push-ups, squats and lunges.
People who did 90 to 119 minutes of strength training each week had a 13% lower risk of premature death from any cause, according to the results. That amount of weekly strength training was also linked to a 19% lower risk of dying from heart disease and a 27% lower risk of dying from neurological or brain diseases.
For cancer deaths, a reduced risk was observed only at lower levels of resistance training, up to 59 minutes per week.
Combining strength training with aerobic activities — such as walking, cycling or swimming — was associated with even greater longevity benefits than strength training alone.
The authors said these findings "support current recommendations encouraging both types of activity to maximize longevity benefits."
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-06-03 23:39
Read more
- Laryngeal Mask Safe for Pediatric Adenotonsillectomies
- Partner Therapeutics Announces Receipt of FDA Commissioner’s National Priority Voucher for Bizengri (zenocutuzumab-zbco) in NRG1 Fusion-Positive Cholangiocarcinoma
- U.S. Overdose Deaths Fell to Pre-Pandemic Levels in 2025
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- Atropine Shows Effect on Superficial Retinal Perfusion
- Camizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% in Patients with Advanced HR-Positive Breast Cancer with an Emergent ESR1 Tumor Mutation in SERENA-6 trial
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions